Kiniksa Pharmaceuticals International, plc (KNSA) vs Kodiak Sciences Inc. (KOD)
A side-by-side comparison of Kiniksa Pharmaceuticals International, plc and Kodiak Sciences Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
KNSA
Kiniksa Pharmaceuticals International, plc
$76.66HealthcareDelayed quote: Oct 6, 2026, 2:20 PM EDT
KOD
Kodiak Sciences Inc.
$94.20HealthcareDelayed quote: Oct 6, 2026, 2:20 PM EDT
Total return — KNSA vs KOD
growth of $100 · dividends reinvested · last 8yKNSA +220.5% (+15.7%/yr)KOD +4521.2% (+61.5%/yr)KOD compounded faster over this window
Log scale — wide-divergence pair
KNSA KOD
KNSA vs KOD: by the numbers
- •KOD is the larger company ($5.89B vs $5.84B market cap).
- •KNSA is profitable (9.59% net margin) while KOD runs a net loss (0.00%).
Metrics side by side
Valuation
| Metric | KNSA | KOD |
|---|---|---|
| P/E ratio | 78.22 | N/A |
| Forward P/E | 55.04 | N/A |
| P/S ratio | 6.95 | N/A |
| P/B ratio | 8.93 | 96.49 |
| EV / EBITDA | 55.61 | N/A |
| FCF yield | 3.13% | N/A |
Profitability
| Metric | KNSA | KOD |
|---|---|---|
| Gross margin | 54.49% | 0.00% |
| Operating margin | 11.92% | 0.00% |
| Net margin | 9.59% | 0.00% |
| ROE | 12.33% | -396.09% |
| ROIC | 9.76% | -115.23% |
Growth (annualized)
| Metric | KNSA | KOD |
|---|---|---|
| Revenue CAGR (5Y) | 155.66% | N/A |
| Total return CAGR (5Y) | 47.48% | 36.19% |
Frequently asked
- Is KNSA or KOD more profitable?
- KNSA runs the higher net margin — KNSA at 9.59% versus KOD at 0.00%.
- How have KNSA and KOD total returns compared?
- Over the past 5 years, KNSA delivered 47.48% and KOD delivered 36.19% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Kiniksa Pharmaceuticals International P/E ratioKiniksa Pharmaceuticals International ROEKodiak Sciences ROEKiniksa Pharmaceuticals International operating marginKodiak Sciences operating marginKiniksa Pharmaceuticals International revenue growthKodiak Sciences revenue growthKiniksa Pharmaceuticals International free cash flowKodiak Sciences free cash flow
Kiniksa Pharmaceuticals International & Kodiak Sciences appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.